日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trial

瑞波替尼治疗NTRK融合阳性晚期实体瘤:一项1/2期试验

Besse, Benjamin; Lin, Jessica J; Bazhenova, Lyudmila; Goto, Koichi; de Langen, Adrianus Johannes; Kim, Dong-Wan; Wolf, Jürgen; Springfeld, Christoph; Popat, Sanjay; Lim, Darren W T; Nagasaka, Misako; Hong, Jung Yong; Baik, Christina S; Hervieu, Alice; Moreno, Victor; Yang, Nong; Kollengode, Kanthi; Yang, Haisu; Xu, Yuanfang; Calvet, Christophe Y; Yuan, Yong; Hammell, Amy B; Drilon, Alexander; Solomon, Benjamin J

R-loop editing by DNA cytosine deaminase APOBEC3B modulates the activity of oestrogen receptor enhancers.

DNA胞嘧啶脱氨酶APOBEC3B对R环的编辑调节雌激素受体增强子的活性。

Zhang Chi, Lu Yu-Jing, Chen Bingjie, Bai Zhiyan, Zeng Qiaoxi, Hervieu Alexia, Licciardello Marco P, Mitsopoulos Konstantinos, Al-Lazikani Bissan, Tortorici Marcello, Rossanese Olivia W, Workman Paul, Clarke Paul A

A phase II study of the AKT inhibitor TAS-117 in patients with advanced solid tumors and germline PTEN mutations

一项针对晚期实体瘤和生殖系 PTEN 突变患者的 AKT 抑制剂 TAS-117 的 II 期研究

Ródon, J; Arkenau, H-T; Funchain, P; Hervieu, A; Anthony, K; Chawla, S P; Laetsch, T W; Murciano-Goroff, Y R; Singer, C F; He, Y; Mina, M; Wacheck, V; Delaloge, S

Differential effects of voluntary exercise and Totum-448, a plant-based formulation, in a hamster model of MASLD

在仓鼠MASLD模型中,自愿运动和植物制剂Totum-448的不同作用

Chavanelle, Vivien; Ennequin, Gaël; Ripoche, Doriane; Otero, Yolanda F; Joubioux, Florian Le; Maugard, Thierry; Hervieu, Valérie; Peltier, Sébastien; Sirvent, Pascal

Comprehensive molecular portrait reveals genetic diversity and distinct molecular subtypes of small intestinal neuroendocrine tumors

综合分子图谱揭示小肠神经内分泌肿瘤的遗传多样性和不同分子亚型

Céline Patte #, Roxane M Pommier #, Anthony Ferrari #, Felicia Fei-Lei Chung #, Maria Ouzounova, Pauline Moullé, Mathieu Richaud, Rita Khoueiry, Maëva Hervieu, Silvia Breusa, Marion Allio, Nicolas Rama, Laura Gérard, Valérie Hervieu, Gilles Poncet, Tanguy Fenouil, Vincent Cahais, Anne-Sophie Sertier

Durvalumab and tremelimumab in combination with metronomic oral vinorelbine for recurrent advanced cervical cancer: an open-label phase I/II study

Durvalumab 和 tremelimumab 联合节拍式口服长春瑞滨治疗复发性晚期宫颈癌:一项开放标签 I/II 期研究

Frenel, Jean-Sébastien; Mathiot, Laurent; Cropet, Claire; Borcoman, Edith; Hervieu, Alice; Coquan, Elodie; De La Motte Rouge, Thibault; Saada-Bouzid, Esma; Sabatier, Renaud; Lavaud, Pernelle; Jimenez, Marta; Legrand, François; Le Saux, Olivia; Charafe, Emmanuelle; Gonçalves, Anthony

MOVIE phase II trial of tremelimumab plus durvalumab combined with metronomic oral vinorelbine in patients with head and neck cancer

MOVIE II期临床试验,评估tremelimumab联合durvalumab和节拍式口服长春瑞滨治疗头颈癌患者的疗效

Borcoman, E; Hervieu, A; Cropet, C; Coquan, E; Guigay, J; Rolland, F; Bernadach, M; Charafe, E; Legrand, F; Dassé, E; Le Tourneau, C; Gonçalves, A

Tremelimumab plus durvalumab combined to metronomic oral vinorelbine: Results from the breast cancer cohort of the phase II MOVIE study

曲美利单抗联合度伐利尤单抗,并配合节拍式口服长春瑞滨:来自 II 期 MOVIE 研究乳腺癌队列的结果

De La Motte Rouge, T; Frenel, J-S; Cropet, C; Borcoman, E; Hervieu, A; Emile, G; Augereau, P; Charafe, E; Legrand, F; Dassé, E; Gonçalves, A

Ultra-High-Frequency-Dielectrophoresis Microfluidic Biosensor to Detect the Transformation Potential of Extracellular Vesicles Derived from Cancer Stem Cells

超高频介电泳微流控生物传感器用于检测源自癌症干细胞的细胞外囊泡的转化潜能

Barthout, Elodie; Lambert, Elisa; Durand, Stéphanie; Hervieu, Céline; Ikhlef, Léa; Saada, Sofiane; Manczak, Rémi; Pannequin, Julie; Pothier, Arnaud; Dalmay, Claire; Lalloué, Fabrice; Mathonnet, Muriel; Bessette, Barbara

Dip-Coating Fabrication of All-Polymer Multilayer Photonic Crystals through 3D Printer Conversion

通过3D打印机转换实现全聚合物多层光子晶体的浸涂制造

Martusciello, Martina; Hervieu, Coralie; Di Fonzo, Daniela; Lanfranchi, Andrea; Lova, Paola; Comoretto, Davide